ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Oxycodone Hydrochloride Extended-Release Drug Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-7K14341
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Oxycodone Hydrochloride Extended Release Drug Market Research Report 2023
BUY CHAPTERS

Global Oxycodone Hydrochloride Extended-Release Drug Market Research Report 2025

Code: QYRE-Auto-7K14341
Report
May 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Teva Pharmaceutical Industries Ltd
Epic Pharma LLC.
Mylan NV
Amneal Pharmaceuticals, Inc.（Impax）
Lifeon Pharmaceutical
Humanwell Healthcare
Mallinckrodt Pharmaceuticals
Pfizer Inc
Purdue Pharma LP

Oxycodone Hydrochloride Extended-Release Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Oxycodone Hydrochloride Extended-Release Drug Market

Oxycodone Hydrochloride Extended-Release Drug Market

The global market for Oxycodone Hydrochloride Extended-Release Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oxycodone Hydrochloride Extended-Release Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oxycodone Hydrochloride Extended-Release Drug.
The Oxycodone Hydrochloride Extended-Release Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oxycodone Hydrochloride Extended-Release Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oxycodone Hydrochloride Extended-Release Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Oxycodone Hydrochloride Extended-Release Drug Market Report

Report Metric Details
Report Name Oxycodone Hydrochloride Extended-Release Drug Market
CAGR 5%
Segment by Type
  • Extended-Release Tablets
  • Extended-Release Capsules
Segment by Application
  • Hospital
  • Clinic
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company PURDUE PHARMA LP, Teva Pharmaceutical Industries Ltd, Epic Pharma, LLC, Mylan, Amneal Pharmaceuticals, Inc.（Impax）, Lifeon Pharmaceutical, Humanwell Healthcare, Mallinckrodt Pharmaceuticals, Pfizer
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Oxycodone Hydrochloride Extended-Release Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Oxycodone Hydrochloride Extended-Release Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Oxycodone Hydrochloride Extended-Release Drug Market report?

Ans: The main players in the Oxycodone Hydrochloride Extended-Release Drug Market are PURDUE PHARMA LP, Teva Pharmaceutical Industries Ltd, Epic Pharma, LLC, Mylan, Amneal Pharmaceuticals, Inc.（Impax）, Lifeon Pharmaceutical, Humanwell Healthcare, Mallinckrodt Pharmaceuticals, Pfizer

What are the Application segmentation covered in the Oxycodone Hydrochloride Extended-Release Drug Market report?

Ans: The Applications covered in the Oxycodone Hydrochloride Extended-Release Drug Market report are Hospital, Clinic

What are the Type segmentation covered in the Oxycodone Hydrochloride Extended-Release Drug Market report?

Ans: The Types covered in the Oxycodone Hydrochloride Extended-Release Drug Market report are Extended-Release Tablets, Extended-Release Capsules

1 Oxycodone Hydrochloride Extended-Release Drug Market Overview
1.1 Product Definition
1.2 Oxycodone Hydrochloride Extended-Release Drug by Type
1.2.1 Global Oxycodone Hydrochloride Extended-Release Drug Market Value Comparison by Type (2024 VS 2031)
1.2.2 Extended-Release Tablets
1.2.3 Extended-Release Capsules
1.3 Oxycodone Hydrochloride Extended-Release Drug by Application
1.3.1 Global Oxycodone Hydrochloride Extended-Release Drug Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Oxycodone Hydrochloride Extended-Release Drug Market Size Estimates and Forecasts
1.4.1 Global Oxycodone Hydrochloride Extended-Release Drug Revenue 2020-2031
1.4.2 Global Oxycodone Hydrochloride Extended-Release Drug Sales 2020-2031
1.4.3 Global Oxycodone Hydrochloride Extended-Release Drug Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Oxycodone Hydrochloride Extended-Release Drug Market Competition by Manufacturers
2.1 Global Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Manufacturers (2020-2025)
2.2 Global Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Oxycodone Hydrochloride Extended-Release Drug Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Oxycodone Hydrochloride Extended-Release Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oxycodone Hydrochloride Extended-Release Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oxycodone Hydrochloride Extended-Release Drug, Product Type & Application
2.7 Global Key Manufacturers of Oxycodone Hydrochloride Extended-Release Drug, Date of Enter into This Industry
2.8 Global Oxycodone Hydrochloride Extended-Release Drug Market Competitive Situation and Trends
2.8.1 Global Oxycodone Hydrochloride Extended-Release Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Oxycodone Hydrochloride Extended-Release Drug Players Market Share by Revenue
2.8.3 Global Oxycodone Hydrochloride Extended-Release Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Oxycodone Hydrochloride Extended-Release Drug Market Scenario by Region
3.1 Global Oxycodone Hydrochloride Extended-Release Drug Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Oxycodone Hydrochloride Extended-Release Drug Sales by Region: 2020-2031
3.2.1 Global Oxycodone Hydrochloride Extended-Release Drug Sales by Region: 2020-2025
3.2.2 Global Oxycodone Hydrochloride Extended-Release Drug Sales by Region: 2026-2031
3.3 Global Oxycodone Hydrochloride Extended-Release Drug Revenue by Region: 2020-2031
3.3.1 Global Oxycodone Hydrochloride Extended-Release Drug Revenue by Region: 2020-2025
3.3.2 Global Oxycodone Hydrochloride Extended-Release Drug Revenue by Region: 2026-2031
3.4 North America Oxycodone Hydrochloride Extended-Release Drug Market Facts & Figures by Country
3.4.1 North America Oxycodone Hydrochloride Extended-Release Drug Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Oxycodone Hydrochloride Extended-Release Drug Sales by Country (2020-2031)
3.4.3 North America Oxycodone Hydrochloride Extended-Release Drug Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oxycodone Hydrochloride Extended-Release Drug Market Facts & Figures by Country
3.5.1 Europe Oxycodone Hydrochloride Extended-Release Drug Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Oxycodone Hydrochloride Extended-Release Drug Sales by Country (2020-2031)
3.5.3 Europe Oxycodone Hydrochloride Extended-Release Drug Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oxycodone Hydrochloride Extended-Release Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Oxycodone Hydrochloride Extended-Release Drug Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Oxycodone Hydrochloride Extended-Release Drug Sales by Region (2020-2031)
3.6.3 Asia Pacific Oxycodone Hydrochloride Extended-Release Drug Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Oxycodone Hydrochloride Extended-Release Drug Market Facts & Figures by Country
3.7.1 Latin America Oxycodone Hydrochloride Extended-Release Drug Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Oxycodone Hydrochloride Extended-Release Drug Sales by Country (2020-2031)
3.7.3 Latin America Oxycodone Hydrochloride Extended-Release Drug Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Oxycodone Hydrochloride Extended-Release Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Oxycodone Hydrochloride Extended-Release Drug Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Oxycodone Hydrochloride Extended-Release Drug Sales by Country (2020-2031)
3.8.3 Middle East and Africa Oxycodone Hydrochloride Extended-Release Drug Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oxycodone Hydrochloride Extended-Release Drug Sales by Type (2020-2031)
4.1.1 Global Oxycodone Hydrochloride Extended-Release Drug Sales by Type (2020-2025)
4.1.2 Global Oxycodone Hydrochloride Extended-Release Drug Sales by Type (2026-2031)
4.1.3 Global Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Type (2020-2031)
4.2 Global Oxycodone Hydrochloride Extended-Release Drug Revenue by Type (2020-2031)
4.2.1 Global Oxycodone Hydrochloride Extended-Release Drug Revenue by Type (2020-2025)
4.2.2 Global Oxycodone Hydrochloride Extended-Release Drug Revenue by Type (2026-2031)
4.2.3 Global Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Type (2020-2031)
4.3 Global Oxycodone Hydrochloride Extended-Release Drug Price by Type (2020-2031)
5 Segment by Application
5.1 Global Oxycodone Hydrochloride Extended-Release Drug Sales by Application (2020-2031)
5.1.1 Global Oxycodone Hydrochloride Extended-Release Drug Sales by Application (2020-2025)
5.1.2 Global Oxycodone Hydrochloride Extended-Release Drug Sales by Application (2026-2031)
5.1.3 Global Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Application (2020-2031)
5.2 Global Oxycodone Hydrochloride Extended-Release Drug Revenue by Application (2020-2031)
5.2.1 Global Oxycodone Hydrochloride Extended-Release Drug Revenue by Application (2020-2025)
5.2.2 Global Oxycodone Hydrochloride Extended-Release Drug Revenue by Application (2026-2031)
5.2.3 Global Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Application (2020-2031)
5.3 Global Oxycodone Hydrochloride Extended-Release Drug Price by Application (2020-2031)
6 Key Companies Profiled
6.1 PURDUE PHARMA LP
6.1.1 PURDUE PHARMA LP Company Information
6.1.2 PURDUE PHARMA LP Description and Business Overview
6.1.3 PURDUE PHARMA LP Oxycodone Hydrochloride Extended-Release Drug Sales, Revenue and Gross Margin (2020-2025)
6.1.4 PURDUE PHARMA LP Oxycodone Hydrochloride Extended-Release Drug Product Portfolio
6.1.5 PURDUE PHARMA LP Recent Developments/Updates
6.2 Teva Pharmaceutical Industries Ltd
6.2.1 Teva Pharmaceutical Industries Ltd Company Information
6.2.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
6.2.3 Teva Pharmaceutical Industries Ltd Oxycodone Hydrochloride Extended-Release Drug Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Teva Pharmaceutical Industries Ltd Oxycodone Hydrochloride Extended-Release Drug Product Portfolio
6.2.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
6.3 Epic Pharma, LLC
6.3.1 Epic Pharma, LLC Company Information
6.3.2 Epic Pharma, LLC Description and Business Overview
6.3.3 Epic Pharma, LLC Oxycodone Hydrochloride Extended-Release Drug Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Epic Pharma, LLC Oxycodone Hydrochloride Extended-Release Drug Product Portfolio
6.3.5 Epic Pharma, LLC Recent Developments/Updates
6.4 Mylan
6.4.1 Mylan Company Information
6.4.2 Mylan Description and Business Overview
6.4.3 Mylan Oxycodone Hydrochloride Extended-Release Drug Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Mylan Oxycodone Hydrochloride Extended-Release Drug Product Portfolio
6.4.5 Mylan Recent Developments/Updates
6.5 Amneal Pharmaceuticals, Inc.（Impax）
6.5.1 Amneal Pharmaceuticals, Inc.（Impax） Company Information
6.5.2 Amneal Pharmaceuticals, Inc.（Impax） Description and Business Overview
6.5.3 Amneal Pharmaceuticals, Inc.（Impax） Oxycodone Hydrochloride Extended-Release Drug Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Amneal Pharmaceuticals, Inc.（Impax） Oxycodone Hydrochloride Extended-Release Drug Product Portfolio
6.5.5 Amneal Pharmaceuticals, Inc.（Impax） Recent Developments/Updates
6.6 Lifeon Pharmaceutical
6.6.1 Lifeon Pharmaceutical Company Information
6.6.2 Lifeon Pharmaceutical Description and Business Overview
6.6.3 Lifeon Pharmaceutical Oxycodone Hydrochloride Extended-Release Drug Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Lifeon Pharmaceutical Oxycodone Hydrochloride Extended-Release Drug Product Portfolio
6.6.5 Lifeon Pharmaceutical Recent Developments/Updates
6.7 Humanwell Healthcare
6.7.1 Humanwell Healthcare Company Information
6.7.2 Humanwell Healthcare Description and Business Overview
6.7.3 Humanwell Healthcare Oxycodone Hydrochloride Extended-Release Drug Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Humanwell Healthcare Oxycodone Hydrochloride Extended-Release Drug Product Portfolio
6.7.5 Humanwell Healthcare Recent Developments/Updates
6.8 Mallinckrodt Pharmaceuticals
6.8.1 Mallinckrodt Pharmaceuticals Company Information
6.8.2 Mallinckrodt Pharmaceuticals Description and Business Overview
6.8.3 Mallinckrodt Pharmaceuticals Oxycodone Hydrochloride Extended-Release Drug Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Mallinckrodt Pharmaceuticals Oxycodone Hydrochloride Extended-Release Drug Product Portfolio
6.8.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
6.9 Pfizer
6.9.1 Pfizer Company Information
6.9.2 Pfizer Description and Business Overview
6.9.3 Pfizer Oxycodone Hydrochloride Extended-Release Drug Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Pfizer Oxycodone Hydrochloride Extended-Release Drug Product Portfolio
6.9.5 Pfizer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oxycodone Hydrochloride Extended-Release Drug Industry Chain Analysis
7.2 Oxycodone Hydrochloride Extended-Release Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oxycodone Hydrochloride Extended-Release Drug Production Mode & Process Analysis
7.4 Oxycodone Hydrochloride Extended-Release Drug Sales and Marketing
7.4.1 Oxycodone Hydrochloride Extended-Release Drug Sales Channels
7.4.2 Oxycodone Hydrochloride Extended-Release Drug Distributors
7.5 Oxycodone Hydrochloride Extended-Release Drug Customer Analysis
8 Oxycodone Hydrochloride Extended-Release Drug Market Dynamics
8.1 Oxycodone Hydrochloride Extended-Release Drug Industry Trends
8.2 Oxycodone Hydrochloride Extended-Release Drug Market Drivers
8.3 Oxycodone Hydrochloride Extended-Release Drug Market Challenges
8.4 Oxycodone Hydrochloride Extended-Release Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Teva Pharmaceutical Industries Ltd
Epic Pharma LLC.
Mylan NV
Amneal Pharmaceuticals, Inc.（Impax）
Lifeon Pharmaceutical
Humanwell Healthcare
Mallinckrodt Pharmaceuticals
Pfizer Inc
Purdue Pharma LP
List of Tables
 Table 1. Global Oxycodone Hydrochloride Extended-Release Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Oxycodone Hydrochloride Extended-Release Drug Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Oxycodone Hydrochloride Extended-Release Drug Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Oxycodone Hydrochloride Extended-Release Drug Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Oxycodone Hydrochloride Extended-Release Drug Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Oxycodone Hydrochloride Extended-Release Drug Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Oxycodone Hydrochloride Extended-Release Drug Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Oxycodone Hydrochloride Extended-Release Drug, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Oxycodone Hydrochloride Extended-Release Drug, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Oxycodone Hydrochloride Extended-Release Drug, Product Type & Application
 Table 12. Global Key Manufacturers of Oxycodone Hydrochloride Extended-Release Drug, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Oxycodone Hydrochloride Extended-Release Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oxycodone Hydrochloride Extended-Release Drug as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Oxycodone Hydrochloride Extended-Release Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Oxycodone Hydrochloride Extended-Release Drug Sales by Region (2020-2025) & (K Units)
 Table 18. Global Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Region (2020-2025)
 Table 19. Global Oxycodone Hydrochloride Extended-Release Drug Sales by Region (2026-2031) & (K Units)
 Table 20. Global Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Region (2026-2031)
 Table 21. Global Oxycodone Hydrochloride Extended-Release Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Region (2020-2025)
 Table 23. Global Oxycodone Hydrochloride Extended-Release Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Region (2026-2031)
 Table 25. North America Oxycodone Hydrochloride Extended-Release Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Oxycodone Hydrochloride Extended-Release Drug Sales by Country (2020-2025) & (K Units)
 Table 27. North America Oxycodone Hydrochloride Extended-Release Drug Sales by Country (2026-2031) & (K Units)
 Table 28. North America Oxycodone Hydrochloride Extended-Release Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Oxycodone Hydrochloride Extended-Release Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Oxycodone Hydrochloride Extended-Release Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Oxycodone Hydrochloride Extended-Release Drug Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Oxycodone Hydrochloride Extended-Release Drug Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Oxycodone Hydrochloride Extended-Release Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Oxycodone Hydrochloride Extended-Release Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Oxycodone Hydrochloride Extended-Release Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Oxycodone Hydrochloride Extended-Release Drug Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Oxycodone Hydrochloride Extended-Release Drug Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Oxycodone Hydrochloride Extended-Release Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Oxycodone Hydrochloride Extended-Release Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Oxycodone Hydrochloride Extended-Release Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Oxycodone Hydrochloride Extended-Release Drug Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Oxycodone Hydrochloride Extended-Release Drug Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Oxycodone Hydrochloride Extended-Release Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Oxycodone Hydrochloride Extended-Release Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Oxycodone Hydrochloride Extended-Release Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Oxycodone Hydrochloride Extended-Release Drug Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Oxycodone Hydrochloride Extended-Release Drug Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Oxycodone Hydrochloride Extended-Release Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Oxycodone Hydrochloride Extended-Release Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Oxycodone Hydrochloride Extended-Release Drug Sales (K Units) by Type (2020-2025)
 Table 51. Global Oxycodone Hydrochloride Extended-Release Drug Sales (K Units) by Type (2026-2031)
 Table 52. Global Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Type (2020-2025)
 Table 53. Global Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Type (2026-2031)
 Table 54. Global Oxycodone Hydrochloride Extended-Release Drug Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Oxycodone Hydrochloride Extended-Release Drug Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Type (2020-2025)
 Table 57. Global Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Type (2026-2031)
 Table 58. Global Oxycodone Hydrochloride Extended-Release Drug Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Oxycodone Hydrochloride Extended-Release Drug Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Oxycodone Hydrochloride Extended-Release Drug Sales (K Units) by Application (2020-2025)
 Table 61. Global Oxycodone Hydrochloride Extended-Release Drug Sales (K Units) by Application (2026-2031)
 Table 62. Global Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Application (2020-2025)
 Table 63. Global Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Application (2026-2031)
 Table 64. Global Oxycodone Hydrochloride Extended-Release Drug Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Oxycodone Hydrochloride Extended-Release Drug Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Application (2020-2025)
 Table 67. Global Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Application (2026-2031)
 Table 68. Global Oxycodone Hydrochloride Extended-Release Drug Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Oxycodone Hydrochloride Extended-Release Drug Price (US$/Unit) by Application (2026-2031)
 Table 70. PURDUE PHARMA LP Company Information
 Table 71. PURDUE PHARMA LP Description and Business Overview
 Table 72. PURDUE PHARMA LP Oxycodone Hydrochloride Extended-Release Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. PURDUE PHARMA LP Oxycodone Hydrochloride Extended-Release Drug Product
 Table 74. PURDUE PHARMA LP Recent Developments/Updates
 Table 75. Teva Pharmaceutical Industries Ltd Company Information
 Table 76. Teva Pharmaceutical Industries Ltd Description and Business Overview
 Table 77. Teva Pharmaceutical Industries Ltd Oxycodone Hydrochloride Extended-Release Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Teva Pharmaceutical Industries Ltd Oxycodone Hydrochloride Extended-Release Drug Product
 Table 79. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
 Table 80. Epic Pharma, LLC Company Information
 Table 81. Epic Pharma, LLC Description and Business Overview
 Table 82. Epic Pharma, LLC Oxycodone Hydrochloride Extended-Release Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Epic Pharma, LLC Oxycodone Hydrochloride Extended-Release Drug Product
 Table 84. Epic Pharma, LLC Recent Developments/Updates
 Table 85. Mylan Company Information
 Table 86. Mylan Description and Business Overview
 Table 87. Mylan Oxycodone Hydrochloride Extended-Release Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Mylan Oxycodone Hydrochloride Extended-Release Drug Product
 Table 89. Mylan Recent Developments/Updates
 Table 90. Amneal Pharmaceuticals, Inc.（Impax） Company Information
 Table 91. Amneal Pharmaceuticals, Inc.（Impax） Description and Business Overview
 Table 92. Amneal Pharmaceuticals, Inc.（Impax） Oxycodone Hydrochloride Extended-Release Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Amneal Pharmaceuticals, Inc.（Impax） Oxycodone Hydrochloride Extended-Release Drug Product
 Table 94. Amneal Pharmaceuticals, Inc.（Impax） Recent Developments/Updates
 Table 95. Lifeon Pharmaceutical Company Information
 Table 96. Lifeon Pharmaceutical Description and Business Overview
 Table 97. Lifeon Pharmaceutical Oxycodone Hydrochloride Extended-Release Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Lifeon Pharmaceutical Oxycodone Hydrochloride Extended-Release Drug Product
 Table 99. Lifeon Pharmaceutical Recent Developments/Updates
 Table 100. Humanwell Healthcare Company Information
 Table 101. Humanwell Healthcare Description and Business Overview
 Table 102. Humanwell Healthcare Oxycodone Hydrochloride Extended-Release Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Humanwell Healthcare Oxycodone Hydrochloride Extended-Release Drug Product
 Table 104. Humanwell Healthcare Recent Developments/Updates
 Table 105. Mallinckrodt Pharmaceuticals Company Information
 Table 106. Mallinckrodt Pharmaceuticals Description and Business Overview
 Table 107. Mallinckrodt Pharmaceuticals Oxycodone Hydrochloride Extended-Release Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Mallinckrodt Pharmaceuticals Oxycodone Hydrochloride Extended-Release Drug Product
 Table 109. Mallinckrodt Pharmaceuticals Recent Developments/Updates
 Table 110. Pfizer Company Information
 Table 111. Pfizer Description and Business Overview
 Table 112. Pfizer Oxycodone Hydrochloride Extended-Release Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Pfizer Oxycodone Hydrochloride Extended-Release Drug Product
 Table 114. Pfizer Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Oxycodone Hydrochloride Extended-Release Drug Distributors List
 Table 118. Oxycodone Hydrochloride Extended-Release Drug Customers List
 Table 119. Oxycodone Hydrochloride Extended-Release Drug Market Trends
 Table 120. Oxycodone Hydrochloride Extended-Release Drug Market Drivers
 Table 121. Oxycodone Hydrochloride Extended-Release Drug Market Challenges
 Table 122. Oxycodone Hydrochloride Extended-Release Drug Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Oxycodone Hydrochloride Extended-Release Drug
 Figure 2. Global Oxycodone Hydrochloride Extended-Release Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Oxycodone Hydrochloride Extended-Release Drug Market Share by Type: 2024 & 2031
 Figure 4. Extended-Release Tablets Product Picture
 Figure 5. Extended-Release Capsules Product Picture
 Figure 6. Global Oxycodone Hydrochloride Extended-Release Drug Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Oxycodone Hydrochloride Extended-Release Drug Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Global Oxycodone Hydrochloride Extended-Release Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Oxycodone Hydrochloride Extended-Release Drug Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Oxycodone Hydrochloride Extended-Release Drug Sales (2020-2031) & (K Units)
 Figure 13. Global Oxycodone Hydrochloride Extended-Release Drug Average Price (US$/Unit) & (2020-2031)
 Figure 14. Oxycodone Hydrochloride Extended-Release Drug Report Years Considered
 Figure 15. Oxycodone Hydrochloride Extended-Release Drug Sales Share by Manufacturers in 2024
 Figure 16. Global Oxycodone Hydrochloride Extended-Release Drug Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Oxycodone Hydrochloride Extended-Release Drug Players: Market Share by Revenue in Oxycodone Hydrochloride Extended-Release Drug in 2024
 Figure 18. Oxycodone Hydrochloride Extended-Release Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Oxycodone Hydrochloride Extended-Release Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Country (2020-2031)
 Figure 21. North America Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Country (2020-2031)
 Figure 22. United States Oxycodone Hydrochloride Extended-Release Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Oxycodone Hydrochloride Extended-Release Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Country (2020-2031)
 Figure 25. Europe Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Oxycodone Hydrochloride Extended-Release Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Oxycodone Hydrochloride Extended-Release Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Oxycodone Hydrochloride Extended-Release Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Oxycodone Hydrochloride Extended-Release Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Oxycodone Hydrochloride Extended-Release Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Region (2020-2031)
 Figure 33. China Oxycodone Hydrochloride Extended-Release Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Oxycodone Hydrochloride Extended-Release Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Oxycodone Hydrochloride Extended-Release Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Oxycodone Hydrochloride Extended-Release Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Oxycodone Hydrochloride Extended-Release Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Oxycodone Hydrochloride Extended-Release Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Oxycodone Hydrochloride Extended-Release Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Country (2020-2031)
 Figure 41. Latin America Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico Oxycodone Hydrochloride Extended-Release Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil Oxycodone Hydrochloride Extended-Release Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina Oxycodone Hydrochloride Extended-Release Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Colombia Oxycodone Hydrochloride Extended-Release Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Oxycodone Hydrochloride Extended-Release Drug Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Oxycodone Hydrochloride Extended-Release Drug Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Oxycodone Hydrochloride Extended-Release Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Oxycodone Hydrochloride Extended-Release Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Oxycodone Hydrochloride Extended-Release Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Oxycodone Hydrochloride Extended-Release Drug by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Oxycodone Hydrochloride Extended-Release Drug by Type (2020-2031)
 Figure 53. Global Oxycodone Hydrochloride Extended-Release Drug Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Oxycodone Hydrochloride Extended-Release Drug by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Oxycodone Hydrochloride Extended-Release Drug by Application (2020-2031)
 Figure 56. Global Oxycodone Hydrochloride Extended-Release Drug Price (US$/Unit) by Application (2020-2031)
 Figure 57. Oxycodone Hydrochloride Extended-Release Drug Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Oxycodone Hydrochloride Drugs Market Research Report 2024
Global Oxycodone Hydrochloride API Market Research Report 2024
Global Oxycodone Hydrochloride Extended Release Tablets Market Research Report 2024
Global Oxycodone Hydrochloride Analgesic Market Research Report 2024
Global Oxybutynin Hydrochloride API Market Research Report 2025
Global Oxycodone Hydrochloride Capsules Market Research Report 2024
Global Oxytocic Pharmaceutical Market Research Report 2025
Global Opioid Analgesics Market Research Report 2025
Global OTC Painkillers Market Research Report 2024
Pain Relievers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Post operative Pain Therapeutics Market Research Report 2025
Pain Reliever Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharmaceutical Hydrocolloids Market Research Report 2025
Global OTC Pain Medicines Market Research Report 2024
Pain Relief Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharma Sustained Release Agent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Prescription Pain Relievers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Chronic Pain Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Opioid Antagonist Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Absorbable Pain Relievers for External Use Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions